Introduction {#s1}
============

Cardiovascular diseases are responsible for about one-third of all deaths in the United States. Acute coronary syndromes (ACS) constitute one in every five deaths, with the ST-segment elevation myocardial infarction (STEMI) representing 30-45% of all ACS \[[@R01]\]. This highlights the importance of prompt management of STEMI in order to preserve cardiac contractility and decrease mortality \[[@R02], [@R03]\]. The estimated increase in 1-year mortality is about 7.5% for every 30-min delay in STEMI reperfusion therapy \[[@R04]\]. Many trials showed that revascularization with percutaneous coronary intervention (PCI) is superior to thrombolytic therapy for acute STEMI but time is of an essence here \[[@R05], [@R06]\].

The American College of Cardiology (ACC) has provided recommendations for the management of STEMI that PCI should be performed within 90 min of STEMI presentation. Despite these recommendations, less than half of patients receive PCI within this time frame \[[@R07], [@R08]\]. This led to the introduction of various strategies such as use of prehospital electrocardiography (ECG), centralized alert system to activate the catheterization lab and availability of 24/7 emergency response team, all to improve the door to balloon (DTB) time in patients receiving primary PCI \[[@R9], [@R10]\]. Additionally, ACC gave recommendations that advanced cardiac life support providers should be able to perform and evaluate the 12-lead ECG routinely on all patients with suspected STEMI \[[@R07]\].

Despite these measures, there has been a significant delay in DTB timing for STEMI patients risking millions of lives. This could be attributed to a confounding variable in meeting the above mentioned ACC guidelines that is DTB highly variable for the time of day or day of the week for STEMI patients. In this study, we sought to determine the DTB time difference for patients presenting during daytime with respect to night time. We also aimed to identify the sources of delay by looking into the different fragment of standard ACC model, that is, prehospital ECG coupled with a centralized emergency department notification, "Cath Alert" in the hospital system, staff availability, delay in the emergency room (ER) and transmission of ECG, while the patient is *en route* to a receiving station in the ER.

Materials and Methods {#s2}
=====================

This study was conducted at Abington Hospital - Jefferson Health, a receiving hospital serving a large suburban and rural community. All acute STEMI patients who had primary PCI done with or without stent placement were deemed eligible for inclusion into the study. The hospital has a 24-h on-call coronary catheterization team consisting of an interventional cardiologist, specialized nurses, a cardiology fellow, ancillary staff and transport personnel. The catheterization laboratory is located on the first floor, while the emergency department is on the ground floor of the same building. This study did not involve direct patient interaction or animal subjects and was approved by the hospital ethics committee and Institutional Review Board.

Study population {#s2a}
----------------

We performed a retrospective single centered study including patients from 2015 to 2018. A total of 436 acute STEMI patients presented either directly, transferred from Lansdale Hospital to the emergency department or directly to the catheterization lab were included in the study. STEMI was defined as ≥ 1 mm in at least two contiguous ECG leads or new onset of complete left bundle-branch block, while treatment with primary PCI was angioplasty with or without stent deployment. Patients with prior fibrinolytic treatment or presenting on weekends were excluded from the study. DTB time was calculated by the time from the first ECG showing STEMI to first inflation of balloon PCI.

Data collection and analysis {#s2b}
----------------------------

For all the included patients, the demographic (age and gender) and clinical information was collected by retrospective chart review. The clinical data included baseline characteristics and risk factors for STEMI such as hypertension, diabetes mellitus (DM), smoking, hypercholesterolemia, prior history of coronary artery disease (CAD), PCI or bypass surgery. All patients were randomized into two groups based on time of presentation. Group A included patients who had PCI done from 6 am to 6 pm and group B included patients who had PCI done from 6 pm to 6 am. Serum troponin levels were determined before and after PCI for each of the two groups. Similarly, postprocedure left ventricular ejection fraction (LVEF) on transthoracic echocardiography was compared with preprocedure LVEF by looking at the medical record. For each group, the femoral and radial approaches of PCI were also taken into consideration. In-hospital mortality and readmission rates for discharged patients were also calculated for each group.

This study was approved by ethics committee and by the Institutional Review Board of our center. Continuous variables were compared using the independent *t*-test and nominal variables by using the χ^2^ and Fisher's exact test using SPSS version 2.0. Values of P ≤ 0.05 were considered significant.

Results {#s3}
=======

The baseline characteristics in the two groups are summarized in [Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}. The mean age of all of the patients was 65.68 years (standard deviation (SD): 14.09). The mean age of the patients presenting at night was 64.56 years (SD: 13.88) against 66.39 years (SD: 14.21) in patients who presented during the day. Patients who presented during the day were 57.70% (n = 161/279) males, versus the patients presenting at night, amongst whom 68.79% (n = 108/157) were males.

###### Baseline Patient Characteristics

                     Time of the day        
  ------------------ ---------------------- ----------------------
  Mean age (years)   64.56                  66.39
  Sex (males)        68.79% (n = 108/157)   57.70% (n = 161/279)
  CHF                12.10% (n = 19/157)    6.45% (n = 18/279)
  Known CAD          25.47% (n = 40/157)    17.20% (n = 48/279)
  Smokers            61.14% (n = 96/157)    44.44% (n = 124/279)
  HLD                27.38% (n = 43/157)    20.7% (n = 58/279)
  PVD                1.27% (n = 2/157)      3.58% (n = 10/279)
  DM                 22.92% (n = 36/157)    21.50% (n = 60/279)
  HTN                58.59% (n = 92/157)    47.31% (n = 132/279)

CHF: congestive heart failure; CAD: coronary artery disease; HLD: hyperlipidemia; PVD: peripheral vascular disease; DM: diabetes mellitus; HTN: hypertension.
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Smoking was very common in our patient population, and 61.14% (n = 96/157) of the patients presenting at night were current or prior smokers. This rate was 44.44% (n = 124/279) in patients presenting during the day. Hypertension was the most common co-morbidity, with 58.59% (n = 92/157) of the patients presenting during the night, and 47.31% (n = 132/279) patients presenting during the day. Hyperlipidemia and diabetes were also common. Hyperlipidemia was present in 27.38% (n = 43/157) of the patients in the night group, and in 20.7% (n = 58/279) during the day group. Diabetes was present in 22.92% (n = 36/157) patients during the night, and in 21.50% (n = 60/279) of the patients presenting during the day. Besides this, peripheral vascular disease was present in 1.27% (n = 2/157) patients presenting during the day and in 3.58% (n = 10/279) patients presenting during the night. Pre-existing heart failure was present in 12.10% (n = 19/157) patients in the night group and in 6.45% (n = 18/279) patients in the day group. Of the patients, 25.47% (n = 40/157) in the night group also had known CAD and 17.20% (n = 48/279) in the day group had known CAD.

All the values are means with standard errors, unless mentioned otherwise. The mean DTB time during the day was 81.29 ± 3.26, which was shoter than the mean DTB time at night (97.30 ± 8.54). There was the homogeneity of variances, as assessed by Levene's test for equality of variances with P value of 0.118 (P \> 0.05). The mean DTB time during the day was -16.05 ± 8.20 (95% confidence interval (CI): -39.17 to 2.21) as compared to the mean DTB time during the night. However, the P-value was 0.051 (P \> 0.05), signifying no statistical significance between the two groups in the DTB time. Four patients presenting during the night did not have a calculated DTB time as PCI was not performed. This is depicted in [Figure 2](#F2){ref-type="fig"}.

![The mean door to balloon times in both groups.](cr-10-150-g002){#F2}

Interestingly, the mean troponin rise during the day was 71.75 ± 7.18, which was higher than the mean troponin rise at night (69.80 ± 7.18). There was the homogeneity of variances, as assessed by Levene's test for equality of variances with P value of 0.50 (P \> 0.05). The mean troponin rise during the day was 1.94 ± 10.60 SEM (95% CI: -22.70 to 18.90) higher than the mean troponin rise during the night. However, the P-value was 0.85 (P \> 0.05), signifying no statistical significance between the two groups in the troponin rise. This is shown in [Figure 3](#F3){ref-type="fig"}.

![Mean troponin I rise in both groups.](cr-10-150-g003){#F3}

Very few patients had a decrease in LVEF, on average a mean fall in LVEF of just 0.93% in patients presenting during the day vs. 0.90% during the night, with a P-value of 0.94 that was also not statistically significant. This is depicted in [Figure 4](#F4){ref-type="fig"}.

![Mean differences in the left ventricular ejection fraction in both groups.](cr-10-150-g004){#F4}

A total of 14 patients were readmitted in 30 days, of which nine had initially presented during the day and five during the night. Two readmissions were due to a fall, three due to dyspnea and nine due to chest pain. Out of the chest pain group, one patient had stent thrombosis and one patient had pericarditis. Three patients died during the study, two of whom presented during the night and one during the day. The mortality and readmission data were too insignificant to analyze. This is depicted in [Table 2](#T2){ref-type="table"}.

###### Outcomes and Complications in Both Groups

                       Time of the day      
  -------------------- -------------------- --------------------
  CVA                  1.91% (n = 3/157)    1.07% (n = 3/279)
  New HF               7.64% (n = 12/157)   5.37% (n = 15/279)
  Cardiogenic shock    7.64% (n = 12/157)   7.88% (n = 22/279)
  Mortality            1.27% (n = 2/157)    0.3% (n = 1/279)
  30-day readmission   3.18% (n = 5/157)    3.22% (n = 9/279)

CVA: cerebrovascular accident; HF: heart failure.

Discussion {#s4}
==========

This study unmasked the importance of intervention time in acute STEMI patients undergoing primary PCI. Although there was no statistically significant difference in the intervention time, ejection fraction or troponin peaks for the day vs. night time groups, there was about 20 min delay in the DTB timing for night group. The broad CI here signifies that larger population studies and multicentered approach might make the difference significant by increasing the power of the study. There was no increase in the in-hospital or long-term mortality for these groups which signifies the fact that the ACG DTB guidelines have been effective and institution was compliant to the recommendations. Moreover, in our study, the angiographic, clinical outcomes in terms of hospital stay, complications and procedural success are different between the two groups.

It is believed that night time intervention is not an independent predictor of in-hospital mortality for STEMI patients as the burden of PCI procedure can be high at night \[[@R11]\]. Some authors believe that there is a peak in platelet aggregation and increase in the viscosity of blood at night bringing variation in the coronary blood flow at night \[[@R12]\]. However, in our study, the trend was opposite and more frequent PCI procedures were observed during the day time. This can be attributed to the postulation that most older and female patients perhaps wait for the daytime for hospital admission especially in cases of subtle or atypical symptoms.

Most studies have suggested that the postprocedural success is lower for PCI done at night and there have been reports of higher in-hospital mortality in these groups \[[@R12]-[@R14]\]. Magid et al in their study established that the DTB time and mortality were significantly higher for off times than for regular hours (116.1 vs. 94.8 min, P \< 0.001 and odds ratio (OR): 1.07; 95% CI: 1.01 - 1.14; P = 0.02, respectively) \[[@R11]\]. Similar findings were reported by Glaser et al, that the in-hospital mortality was significantly higher in off hours PCI procedures (OR: 2.66, 95% CI: 1.39 - 4.56; P = 0.002) \[[@R15]\]. Our study, however, excluded the population who had PCI on the weekends, but the night time PCI procedure or STEMI-related mortality was not different from the daytime mortality.

"MITRA" trial also showed that the DTB time was significantly higher in patients presenting at night times compared to those presenting during peak hours \[[@R16], [@R17]\]. There was a 9 min in-hospital delay in MITRA trial for the night time vs. day PCI (85 min day, 94 min night, P = 0.037) which was ironically statistically significant in contrast to our study where the average difference is higher but there is no statistical significance \[[@R16]\]. Interestingly, the prehospital delay for night time PCI was 60 min shorter than daytime with a P value of 0.005 for those patients \[[@R16]\]. This could be due to the fact that transportation is easier at night than day rush hours. These findings were substantiated by "CADILLAC" trial where DTB time for night was 129 vs. 108 min for daytime (P \< 0.0001) \[[@R17]\]. Ortolani et al found that patients treated during off hours had a reperfusion time 20 min higher than (199 vs. 179 min, P = 0.052) regular hours \[[@R18]\]. Despite the reported delays due to time variations, there was no statistical difference in the clinical course and outcomes of the two groups \[[@R18]\]. The findings of our study are consistent with these trials but our study is different from these trials as we excluded patients presenting on weekends to reduce the subjective bias. The ancillary staff, transportation and cardiologists on weekends are different on weekends which can change the results.

The peak troponin and change in ejection fraction were used as a marker of damage to the myocardium in our study. There was no statistical difference in these findings for the two groups despite the DTB time delay of about 20 min on average in the whole population. Furthermore to reduce the confounding factors both groups in our study were matched on the basis of their comorbidities, average age and gender. In MITRA trial, the in-hospital mortality was about 7.9%, while CADILLAC trail calculated 30 days mortality which was 2%; in our study this number was just 0.68% (3/436) in the whole patient population \[[@R16], [@R17]\]. It was 1.27% (n = 2/157) in the patients presenting at night and 0.3% (n = 1/279) in patients presenting during the day. This figure was too small to analyze. Our study is different from these trials as we did not exclude patients with cardiogenic shock and all risk factors for STEMI were taken into account.

Our results highlight the importance of the time sensitive approach to STEMI. All attempts to shorten the DTB time should be taken. Some suggestions are to unite small centers and have a larger high volume angioplasty center with 24/7 availability of the staff and expert interventional cardiologists. In-patient hospital delay can be avoided by bypassing the ER, centralized system where ECG can be transferred directly to the on-call cardiologist and cardiac cath lab should be kept informed by the EMS once a patient is transported. Patient transportation can be expedited by the use of helicopter and the first responders to STEMI should be trained to identify ischemic changes on ECG. Our findings are consistent with previous studies, where STEMI patients treated at large centers have a lower mortality than low-volume centers \[[@R19]\]. The ACC suggests that primary PCI should be used only if performed by cardiologist with experience of \> 75 elective PCIs/year and at least 11 primary PCIs/year and by institutions doing \> 400 elective and \> 36 primary PCIs/year \[[@R20]\]. This may be the reason the outcomes are better at our institution as we perform \> 600 PCIs/year and have expert interventional cardiologists.

There are certain limitations of this study: the study was single center and the population included was small. Moreover, it was a retrospective study, so randomization could not be done. But efforts were made to make the two groups as comparable as possible.

Conclusion {#s4a}
----------

This study shows that patients treated at night with respect to daytimes by primary PCI have different DTB times, but this difference may not be as clinically relevant as initially thought. The presentation, clinical outcomes, hospital stays, complication rates and 30 days mortality may not be statistically different, provided the PCI is performed at a high-volume angioplasty center and the staff is experienced.

Summary {#s4b}
-------

What is already known about this subject? 1) There is a significant difference between DTB time in patients presenting at night than day. 2) This increases the mortality of the patients and cardiac outcomes.

What are the new findings? 1) There is no difference in the DTB time if we exclude weekends and remove confounding factors. 2) If we follow the suggested recommendations, then mortality can be decreased significantly.

How might it impact on clinical practice in the foreseeable future? If the proposed recommendations are followed, then there will be a significant decrease in STEMI-associated mortality. There will be decrease in the devastating outcomes of myocardial infarction by lowering the DTB time for STEMI intervention.
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